AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 9398099 — intervention group
Group type: EXPERIMENTAL
Intervention: Amlodipine
Number of subjects: 32
Study 9398099 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 32
Study 7955242 — intervention group
Group type: EXPERIMENTAL
Intervention: Group B (1990 to 1993) with 'no touch' technique, antegrade and retrograde blood cardioplegia, single aortic cross-clamp
Number of subjects: 131
Study 7955242 — intervention group
Group type: COMPARATOR
Intervention: Group A (1988 to 1989) with standard techniques
Number of subjects: 131
Study 3115138 — intervention group
Group type: EXPERIMENTAL
Intervention: Intrathecal buprenorphine (0.15 mg) plus 20 mg tetracaine
Number of subjects: 29
Study 3115138 — intervention group
Group type: COMPARATOR
Intervention: Control group (20 mg tetracaine only)
Number of subjects: 29
Study 28736918 — intervention group
Group type: EXPERIMENTAL
Intervention: Erenumab (AMG 334), single doses ranging from 1 mg to 70 mg
Number of subjects: 0
Study 28736918 — intervention group
Group type: EXPERIMENTAL
Intervention: Erenumab (AMG 334), multiple doses
Number of subjects: 0
Study 28736918 — intervention group
Group type: EXPERIMENTAL
Intervention: Erenumab (AMG 334)
Number of subjects: 0
Study 25832556 — intervention group
Group type: EXPERIMENTAL
Intervention: Early oral feeding (n=44)
Number of subjects: 89
Study 25832556 — intervention group
Group type: COMPARATOR
Intervention: Late oral feeding (n=45)
Number of subjects: 89
Study 24834772 — intervention group
Group type: EXPERIMENTAL
Intervention: SIT (Allergen-specific immunotherapy)
Number of subjects: 29
Study 24834772 — intervention group
Group type: COMPARATOR
Intervention: Pharmacological treatment (Control)
Number of subjects: 29
Study 22808958 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral immunotherapy (40 children)
Number of subjects: 55
Study 22808958 — intervention group
Group type: COMPARATOR
Intervention: Placebo (15 children)
Number of subjects: 55
Study 20577073 — intervention group
Group type: EXPERIMENTAL
Intervention: Clavicle ORIF
Number of subjects: 132
Study 20577073 — intervention group
Group type: COMPARATOR
Intervention: Nonoperative treatment
Number of subjects: 132
Study 18392659 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic-assisted APR
Number of subjects: 99
Study 18392659 — intervention group
Group type: COMPARATOR
Intervention: Open APR
Number of subjects: 99
Study 16012002 — intervention group
Group type: EXPERIMENTAL
Intervention: Phenoxymethylpenicillin (PcV)
Number of subjects: 0
Study 16012002 — intervention group
Group type: EXPERIMENTAL
Intervention: Loracarbef
Number of subjects: 0
Study 16012002 — intervention group
Group type: EXPERIMENTAL
Intervention: Clindamycin
Number of subjects: 0
Study 16012002 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study 12101110 — intervention group
Group type: EXPERIMENTAL
Intervention: Selenium supplementation (200 microg daily)
Number of subjects: 1312
Study 10577401 — intervention group
Group type: EXPERIMENTAL
Intervention: Emergency medical services (EMS) personnel
Number of subjects: 261
Study 10577401 — intervention group
Group type: EXPERIMENTAL
Intervention: Physicians
Number of subjects: 261
Study 10577401 — intervention group
Group type: EXPERIMENTAL
Intervention: Medical students
Number of subjects: 261
Study 10577401 — intervention group
Group type: EXPERIMENTAL
Intervention: Laypersons
Number of subjects: 261
Study 10577401 — intervention group
Group type: EXPERIMENTAL
Intervention: All participants
Number of subjects: 261
Study 10577401 — intervention group
Group type: EXPERIMENTAL
Intervention: EMS personnel
Number of subjects: 261
Study 8527571 — intervention group
Group type: EXPERIMENTAL
Intervention: Ciprofloxacin
Number of subjects: 23
Study 8527571 — intervention group
Group type: COMPARATOR
Intervention: Trimethoprim
Number of subjects: 23
Study 8527571 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 23
Study 2125547 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluvoxamine (starting at 50 mg for 3 days, increasing to 100 mg for 3 days, then up to 150 mg daily if necessary)
Number of subjects: 20
Study 2125547 — intervention group
Group type: COMPARATOR
Intervention: Imipramine (starting at 50 mg for 3 days, increasing to 100 mg for 3 days, then up to 150 mg daily if necessary)
Number of subjects: 20
Study 7010892 — intervention group
Group type: EXPERIMENTAL
Intervention: Gentamicin beads
Number of subjects: 48
Study 7010892 — intervention group
Group type: COMPARATOR
Intervention: Suction-irrigation drainage
Number of subjects: 48
Study 30500558 — intervention group
Group type: EXPERIMENTAL
Intervention: Enhanced Monitoring arm
Number of subjects: 286
Study 30500558 — intervention group
Group type: EXPERIMENTAL
Intervention: Lifestyle arm
Number of subjects: 286
Study 30500558 — intervention group
Group type: COMPARATOR
Intervention: Usual Care
Number of subjects: 286
Study 29466111 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexamethasone (DEX)
Number of subjects: 54
Study 29466111 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 54
Study 25892374 — intervention group
Group type: EXPERIMENTAL
Intervention: Cervical extensor endurance test (CEET)
Number of subjects: 30
Study 24093935 — intervention group
Group type: EXPERIMENTAL
Intervention: Diagnostic laparoscopy
Number of subjects: 96
Study 24093935 — intervention group
Group type: EXPERIMENTAL
Intervention: Operative laparoscopy
Number of subjects: 96
Study 24093935 — intervention group
Group type: COMPARATOR
Intervention: Open surgery
Number of subjects: 96
Study 22247932 — intervention group
Group type: EXPERIMENTAL
Intervention: Tonic painful mechanical stimulation applied to pericranial muscles by a mechanical headband pressure device at VAS5 intensity for 10 minutes
Number of subjects: 40
Study 19190104 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous sc insulin and pramlintide infusion (part B)
Number of subjects: 13
Study 19190104 — intervention group
Group type: COMPARATOR
Intervention: Continuous sc insulin monotherapy (part A)
Number of subjects: 13
Study 17933161 — intervention group
Group type: EXPERIMENTAL
Intervention: Glidescope
Number of subjects: 106
Study 17933161 — intervention group
Group type: COMPARATOR
Intervention: CTrach
Number of subjects: 106
Study 17933161 — intervention group
Group type: EXPERIMENTAL
Intervention: Both devices
Number of subjects: 106
Study 15328305 — intervention group
Group type: EXPERIMENTAL
Intervention: Resistance training (leg-extension and leg-press exercises, 3 times per week for 14 weeks)
Number of subjects: 9
Study 11157331 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard preoperative and postoperative tube feeding
Number of subjects: 49
Study 11157331 — intervention group
Group type: EXPERIMENTAL
Intervention: Arginine-supplemented preoperative and postoperative tube feeding
Number of subjects: 49
Study 11157331 — intervention group
Group type: COMPARATOR
Intervention: No preoperative and standard postoperative tube feeding (Control)
Number of subjects: 49
Study 9726693 — intervention group
Group type: EXPERIMENTAL
Intervention: 200 mg dexibuprofen
Number of subjects: 16
Study 9726693 — intervention group
Group type: EXPERIMENTAL
Intervention: 400 mg dexibuprofen
Number of subjects: 16
Study 9726693 — intervention group
Group type: EXPERIMENTAL
Intervention: Both dexibuprofen preparations
Number of subjects: 16
Study 7642184 — intervention group
Group type: EXPERIMENTAL
Intervention: Laser-induced temporary scotoma (argon laser exposure)
Number of subjects: 0
Study 7642184 — intervention group
Group type: EXPERIMENTAL
Intervention: Background complexity and target contrast
Number of subjects: 0
Study 7642184 — intervention group
Group type: EXPERIMENTAL
Intervention: Target motion
Number of subjects: 0
Study 7642184 — intervention group
Group type: EXPERIMENTAL
Intervention: Contrast
Number of subjects: 0
Study 2651132 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexamethasone
Number of subjects: 18
Study 2651132 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study 330292 — intervention group
Group type: EXPERIMENTAL
Intervention: Triamcinolone acetonide benzoyl-beta-amino-isobutyrate (TBI)
Number of subjects: 21
Study 330292 — intervention group
Group type: COMPARATOR
Intervention: Betamethasone dipropionate
Number of subjects: 21
Study 30260294 — intervention group
Group type: EXPERIMENTAL
Intervention: JNJ-54175446 (doses ranging from 0.5 to 600 mg)
Number of subjects: 77
Study 30260294 — intervention group
Group type: EXPERIMENTAL
Intervention: JNJ-54175446
Number of subjects: 77
Study 30260294 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 77
Study 27455573 — intervention group
Group type: EXPERIMENTAL
Intervention: Remaxol (single daily intravenous administration, 400 mL at 3-4 mL/min rate) for 3-5 days after thrombolytic therapy
Number of subjects: 126
Study 27455573 — intervention group
Group type: COMPARATOR
Intervention: Conventional thrombolytic therapy
Number of subjects: 126
Study 25514391 — intervention group
Group type: EXPERIMENTAL
Intervention: Low glycemic index multi-nutrient supplement (breakfast replacement)
Number of subjects: 71
Study 25514391 — intervention group
Group type: COMPARATOR
Intervention: Normal breakfast (control group)
Number of subjects: 71
Study 22083390 — intervention group
Group type: EXPERIMENTAL
Intervention: Individual Placement and Support (IPS)
Number of subjects: 312
Study 22083390 — intervention group
Group type: COMPARATOR
Intervention: Conventional vocational training
Number of subjects: 312
Study 20123859 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous Positive Airway Pressure (CPAP) therapy
Number of subjects: 32
Study 20123859 — intervention group
Group type: COMPARATOR
Intervention: No intervention (before CPAP therapy)
Number of subjects: 32
Study 20123859 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous Positive Airway Pressure (CPAP) therapy after 3 months
Number of subjects: 32
Study 18590203 — intervention group
Group type: EXPERIMENTAL
Intervention: Tongyouqing
Number of subjects: 58
Study 18590203 — intervention group
Group type: COMPARATOR
Intervention: tijiaseluo (6 mg, qd)
Number of subjects: 58
Study 15716710 — intervention group
Group type: EXPERIMENTAL
Intervention: Losartan (50 mg/day)
Number of subjects: 51
Study 15716710 — intervention group
Group type: EXPERIMENTAL
Intervention: Ramipril (5 mg/day)
Number of subjects: 51
Study 15716710 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined (losartan 50 mg/day plus ramipril 5 mg/day)
Number of subjects: 51
Study 15716710 — intervention group
Group type: COMPARATOR
Intervention: Hydrochlorothiazide (12.5 mg/day) added as needed
Number of subjects: 51
Study 12742978 — intervention group
Group type: EXPERIMENTAL
Intervention: Rapamycin (n=22)
Number of subjects: 46
Study 12742978 — intervention group
Group type: COMPARATOR
Intervention: Control (continued current immunosuppression, n=24)
Number of subjects: 46
Study 10496543 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupressure
Number of subjects: 84
Study 10496543 — intervention group
Group type: COMPARATOR
Intervention: Sham Acupressure
Number of subjects: 84
Study 10496543 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 84
Study 8721801 — intervention group
Group type: EXPERIMENTAL
Intervention: Enrollment in CAST
Number of subjects: 400
Study 8721801 — intervention group
Group type: EXPERIMENTAL
Intervention: Demographic variables (e.g., being male, not having medical insurance)
Number of subjects: 400
Study 8721801 — intervention group
Group type: EXPERIMENTAL
Intervention: Episodes of ventricular tachycardia
Number of subjects: 400
Study 8721801 — intervention group
Group type: EXPERIMENTAL
Intervention: Health beliefs (e.g., extra beats are harmful, a higher degree of general health concern)
Number of subjects: 400
Study 8721801 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinical trial staff interaction and timing of recruitment
Number of subjects: 400
Study 8721801 — intervention group
Group type: EXPERIMENTAL
Intervention: Health care reform improving access to medical insurance coverage
Number of subjects: 400
Study 8721801 — intervention group
Group type: EXPERIMENTAL
Intervention: Modifiable variables
Number of subjects: 400
Study 1918659 — intervention group
Group type: EXPERIMENTAL
Intervention: Lithium discontinuation
Number of subjects: 0
Study 1918659 — intervention group
Group type: COMPARATOR
Intervention: Inositol administration
Number of subjects: 0
Study 7071805 — intervention group
Group type: COMPARATOR
Intervention: Subcutaneous calcium heparin (5,000 units eight-hourly)
Number of subjects: 0
Study 7071805 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium heparin monitored by maintaining the standardised APTT at 50 secs
Number of subjects: 0
Study 6367723 — intervention group
Group type: EXPERIMENTAL
Intervention: Betaxolol hydrochloride, 0.5%
Number of subjects: 46
Study 6367723 — intervention group
Group type: COMPARATOR
Intervention: Timolol maleate, 0.5%
Number of subjects: 46
Study 31215471 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgical excision of the keloid scar followed by sub-dermal injection of triamcinolone acetonide (2 ampules of 10 mg/1 ml each) at the time of wound closure.
Number of subjects: 150
Study 31215471 — intervention group
Group type: COMPARATOR
Intervention: Surgical excision of the keloid scar without corticosteroid injection (control group).
Number of subjects: 150
Study 29912070 — intervention group
Group type: EXPERIMENTAL
Intervention: Massage therapy
Number of subjects: 60
Study 29912070 — intervention group
Group type: COMPARATOR
Intervention: Standard of care plus three reading visits
Number of subjects: 60
Study 26782027 — intervention group
Group type: EXPERIMENTAL
Intervention: Single puncture arthrocentesis
Number of subjects: 40
Study 26782027 — intervention group
Group type: COMPARATOR
Intervention: Double puncture arthrocentesis
Number of subjects: 40
Study 25285751 — intervention group
Group type: EXPERIMENTAL
Intervention: Tailored intervention (telephone calls and access to a mom-centric website)
Number of subjects: 311
Study 25285751 — intervention group
Group type: COMPARATOR
Intervention: Standard PA website (control)
Number of subjects: 311
Study 25285751 — intervention group
Group type: EXPERIMENTAL
Intervention: Tailored intervention
Number of subjects: 311
Study 22549600 — intervention group
Group type: EXPERIMENTAL
Intervention: Qigong massage methodology delivered by parents and trainers
Number of subjects: 28
Study 22549600 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 28
Study 19800817 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous ultrafiltration
Number of subjects: 60
Study 19800817 — intervention group
Group type: COMPARATOR
Intervention: Conventional ultrafiltration
Number of subjects: 60
Study 18046028 — intervention group
Group type: EXPERIMENTAL
Intervention: Eltrombopag 30 mg daily
Number of subjects: 118
Study 18046028 — intervention group
Group type: EXPERIMENTAL
Intervention: Eltrombopag 50 mg daily
Number of subjects: 118
Study 18046028 — intervention group
Group type: EXPERIMENTAL
Intervention: Eltrombopag 75 mg daily
Number of subjects: 118
Study 18046028 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 118
Study 16237623 — intervention group
Group type: EXPERIMENTAL
Intervention: Active experimental group (endurance exercise, 40 minutes per session at 70-90% heart rate reserve, 7 days/week)
Number of subjects: 40
Study 16237623 — intervention group
Group type: EXPERIMENTAL
Intervention: Sedentary experimental group (endurance exercise, 40 minutes per session at 70-90% heart rate reserve, 7 days/week)
Number of subjects: 40
Study 16237623 — intervention group
Group type: COMPARATOR
Intervention: Control groups (active and sedentary)
Number of subjects: 40
Study 14516881 — intervention group
Group type: EXPERIMENTAL
Intervention: Biphasic truncated exponential (BTE) waveform
Number of subjects: 101
Study 14516881 — intervention group
Group type: COMPARATOR
Intervention: Biphasic rectilinear (BRL) waveform
Number of subjects: 101
Study 14516881 — intervention group
Group type: EXPERIMENTAL
Intervention: Both BTE and BRL waveforms
Number of subjects: 101
Study 12024980 — intervention group
Group type: EXPERIMENTAL
Intervention: Pefloxacin
Number of subjects: 10
Study 12024980 — intervention group
Group type: EXPERIMENTAL
Intervention: Erythromycin
Number of subjects: 10
Study 12024980 — intervention group
Group type: EXPERIMENTAL
Intervention: Augmentin
Number of subjects: 10
Study 12024980 — intervention group
Group type: EXPERIMENTAL
Intervention: Chloramphenicol
Number of subjects: 10
Study 12024980 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefpirom
Number of subjects: 10
Study 12024980 — intervention group
Group type: EXPERIMENTAL
Intervention: Co-trimoxazole
Number of subjects: 10
Study 12024980 — intervention group
Group type: EXPERIMENTAL
Intervention: Ceftriaxone
Number of subjects: 10
Study 12024980 — intervention group
Group type: EXPERIMENTAL
Intervention: Vancomycin
Number of subjects: 10
Study 12024980 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefotaxime
Number of subjects: 10
Study 8544782 — intervention group
Group type: COMPARATOR
Intervention: Conventional isotope dilution technique (Cold-GINF)
Number of subjects: 30
Study 8544782 — intervention group
Group type: EXPERIMENTAL
Intervention: Constant specific activity method (Hot-GINF)
Number of subjects: 30
Study 8544782 — intervention group
Group type: COMPARATOR
Intervention: Low-dose insulin infusion (5, 10, 20 mU . m-2 . min-1)
Number of subjects: 30
Study 8544782 — intervention group
Group type: COMPARATOR
Intervention: High-dose insulin infusion (40, 80, 160 mU . m-2 . min-1)
Number of subjects: 30
Study 1987006 — intervention group
Group type: EXPERIMENTAL
Intervention: 96 meq sodium
Number of subjects: 48
Study 1987006 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 48
Study 6846125 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral verapamil
Number of subjects: 20
Study 31283555 — intervention group
Group type: EXPERIMENTAL
Intervention: True acupuncture
Number of subjects: 204
Study 31283555 — intervention group
Group type: COMPARATOR
Intervention: Sham acupuncture
Number of subjects: 204
Study 31283555 — intervention group
Group type: COMPARATOR
Intervention: Routine care (no acupuncture treatment)
Number of subjects: 204
Study 29157273 — intervention group
Group type: EXPERIMENTAL
Intervention: Daikenchuto (TJ-100)
Number of subjects: 40
Study 25623520 — intervention group
Group type: EXPERIMENTAL
Intervention: Mud-bath therapy (12 mudpacks and 12 thermal baths) with continued TNF inhibitor treatment
Number of subjects: 36
Study 25623520 — intervention group
Group type: COMPARATOR
Intervention: Pharmacological therapy alone (TNF inhibitors)
Number of subjects: 36
Study 24964805 — intervention group
Group type: EXPERIMENTAL
Intervention: Quadrivalent meningococcal conjugate vaccine
Number of subjects: 0
Study 24964805 — intervention group
Group type: COMPARATOR
Intervention: Quadrivalent meningococcal polysaccharide vaccine
Number of subjects: 0
Study 21615805 — intervention group
Group type: EXPERIMENTAL
Intervention: Classical ketogenic diet
Number of subjects: 91
Study 21615805 — intervention group
Group type: EXPERIMENTAL
Intervention: Medium chain triglyceride ketogenic diet
Number of subjects: 91
Study 21615805 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 91
Study 19755070 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative footbath with chlorhexidine gluconate (Hibitane) 20 minutes before surgery
Number of subjects: 44
Study 19755070 — intervention group
Group type: COMPARATOR
Intervention: Placebo footbath
Number of subjects: 44
Study 17312228 — intervention group
Group type: EXPERIMENTAL
Intervention: PCEA+AMB (n = 21, 0.1% ropivacaine + fentanyl 2 microg/mL, bolus 5 mL, lockout 10 min, basal automated boluses of 5 mL/h)
Number of subjects: 42
Study 17312228 — intervention group
Group type: COMPARATOR
Intervention: PCEA+BCI (n = 21, 0.1% ropivacaine + fentanyl 2 microg/mL, bolus 5 mL, lockout 10 min, basal infusion 5 mL/h)
Number of subjects: 42
Study 17312228 — intervention group
Group type: EXPERIMENTAL
Intervention: PCEA+AMB
Number of subjects: 42
Study 17312228 — intervention group
Group type: COMPARATOR
Intervention: PCEA+BCI
Number of subjects: 42
Study 15211441 — intervention group
Group type: EXPERIMENTAL
Intervention: n-3 Polyunsaturated fatty acids (PUFAs) 2.4 g for 8 weeks
Number of subjects: 64
Study 15211441 — intervention group
Group type: COMPARATOR
Intervention: Control treatment (olive oil)
Number of subjects: 64
Study 11208997 — intervention group
Group type: EXPERIMENTAL
Intervention: 0K dialysate
Number of subjects: 12
Study 11208997 — intervention group
Group type: EXPERIMENTAL
Intervention: 1K dialysate
Number of subjects: 12
Study 11208997 — intervention group
Group type: EXPERIMENTAL
Intervention: 2K dialysate
Number of subjects: 12
Study 10696320 — intervention group
Group type: EXPERIMENTAL
Intervention: Tropicamide 1% spray
Number of subjects: 34
Study 10696320 — intervention group
Group type: COMPARATOR
Intervention: Tropicamide 1% eye drops
Number of subjects: 34
Study 9156934 — intervention group
Group type: EXPERIMENTAL
Intervention: Epsilon-aminocaproic acid (EACA) given in a daily dose of 85-230 mg/kg for 1-11 days
Number of subjects: 13
Study 9156934 — intervention group
Group type: EXPERIMENTAL
Intervention: Epsilon-aminocaproic acid (EACA) given with corticosteroids
Number of subjects: 13
Study 9156934 — intervention group
Group type: EXPERIMENTAL
Intervention: Epsilon-aminocaproic acid (EACA)
Number of subjects: 13
Study 1860199 — intervention group
Group type: EXPERIMENTAL
Intervention: Amiodarone
Number of subjects: 77
Study 1860199 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 77
Study 6211996 — intervention group
Group type: EXPERIMENTAL
Intervention: Clindamycin and gentamicin
Number of subjects: 130
Study 6211996 — intervention group
Group type: COMPARATOR
Intervention: Cefamandole
Number of subjects: 130
Study 6211996 — intervention group
Group type: COMPARATOR
Intervention: Cefoperazone
Number of subjects: 130
Study 29618132 — intervention group
Group type: EXPERIMENTAL
Intervention: Isometric exercise (knee extension, 30% maximum voluntary contraction for three minutes)
Number of subjects: 30
Study 29618132 — intervention group
Group type: COMPARATOR
Intervention: Quiet rest
Number of subjects: 30
Study 29271276 — intervention group
Group type: EXPERIMENTAL
Intervention: Telephone-delivered CBT with self-help, CBT recovery manual (TS)
Number of subjects: 89
Study 29271276 — intervention group
Group type: EXPERIMENTAL
Intervention: High support CBT (HS - TAU plus TS plus group sessions)
Number of subjects: 89
Study 29271276 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual (TAU)
Number of subjects: 89
Study 27974112 — intervention group
Group type: EXPERIMENTAL
Intervention: Caffeine treatment
Number of subjects: 59
Study 27974112 — intervention group
Group type: COMPARATOR
Intervention: Control (no caffeine treatment)
Number of subjects: 59
Study 23887680 — intervention group
Group type: COMPARATOR
Intervention: No muscle relaxant (group NR)
Number of subjects: 86
Study 23887680 — intervention group
Group type: EXPERIMENTAL
Intervention: Muscle relaxant (group R)
Number of subjects: 86